Company / Return on Assets (ROA)
Tonix Pharmaceuticals Holding Corp. Return on Assets (ROA) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-46.9%
FY2025
5-year range
-71.6% / -46.9%
FY2023-FY2025
Trend
+34.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -71.4% to -46.9% over the past 2 years.
Based on SEC 10-K filings.
-46.9% in FY2025.
Improved from -71.4% to -46.9% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 34.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -46.9% | +34.5% |
| FY2024 | -71.6% | -0.4% |
| FY2023 | -71.4% | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 28, 2026